BSJ-03-123
2361493-16-3
98%
5kg/bag
2025-10-10
Nootropics,Sarms,Peptides,API,Intermediates
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
N-[2-[2-[2-[2-[4-[6-[(6-Acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide
Other Name:BSJ-03-123;2361493-16-3;N-[2-[2-[2-[2-[4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]ethyl]-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;SCHEMBL22199840;GTPL10532;EX-A3877;s8815;AKOS037653387;CID 137628658;HY-111556
CAS No.:2361493-16-3
Molecular Formula:C47H56N10O11
InChIKeys:LUHCYAOYQIFNRN-UHFFFAOYSA-N
Exact Mass:936.41300264
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nootropics,Sarms,Peptides,API,Intermediates
-
Location:
Kemp House, 160 City Road London, EC1V 2NX
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product